What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Immune system
Terje Espevik spends much of his time researching Tumor necrosis factor alpha, Immunology, Cell biology, Internal medicine and Cytokine.
His study in Tumor necrosis factor alpha is interdisciplinary in nature, drawing from both Molecular biology, Receptor, Monocyte, Proinflammatory cytokine and Transforming growth factor.
His research integrates issues of Cytotoxic T cell and Cytotoxicity in his study of Molecular biology.
His Immunology study combines topics in areas such as Meningitis and Meningococcal disease.
As a part of the same scientific family, he mostly works in the field of Cell biology, focusing on Biochemistry and, on occasion, Cell adhesion molecule and Phagocyte.
His study focuses on the intersection of Internal medicine and fields such as Endocrinology with connections in the field of Heart failure and Biological activity.
His most cited work include:
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals (2205 citations)
- A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. (1177 citations)
- TLR9 signals after translocating from the ER to CpG DNA in the lysosome (1140 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Tumor necrosis factor alpha, Molecular biology, Cell biology and Receptor.
In most of his Immunology studies, his work intersects topics such as Peripheral blood mononuclear cell.
He combines subjects such as Antibody, Cytokine and Monocyte with his study of Tumor necrosis factor alpha.
Many of his research projects under Molecular biology are closely connected to Population with Population, tying the diverse disciplines of science together.
TLR2 is closely connected to Toll-like receptor in his research, which is encompassed under the umbrella topic of Cell biology.
His studies in Receptor integrate themes in fields like Cancer research and Transfection.
He most often published in these fields:
- Immunology (32.92%)
- Tumor necrosis factor alpha (28.88%)
- Molecular biology (23.29%)
What were the highlights of his more recent work (between 2013-2021)?
- Inflammation (15.84%)
- Complement system (10.25%)
- Immunology (32.92%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Inflammation, Complement system, Immunology, Cell biology and Whole blood.
He has included themes like Tumor necrosis factor alpha and Receptor, Innate immune system in his Inflammation study.
His research in Receptor tackles topics such as Molecular biology which are related to areas like Monocyte.
His Immunology research includes elements of Peripheral blood mononuclear cell and Downregulation and upregulation.
His Cell biology study deals with TRIF intersecting with Interferon regulatory factors.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Cardiology.
Between 2013 and 2021, his most popular works were:
- The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation (423 citations)
- Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming (337 citations)
- Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming (166 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Immune system
Terje Espevik mostly deals with Inflammation, Immunology, Complement system, TLR4 and Cell biology.
His studies deal with areas such as Lectin, Whole blood, Very low-density lipoprotein and Receptor, Innate immune system as well as Inflammation.
Terje Espevik works mostly in the field of Complement system, limiting it down to concerns involving Internal medicine and, occasionally, Gastroenterology and Bioinformatics.
The various areas that Terje Espevik examines in his Cell biology study include Inflammasome and Caspase 1.
His TLR2 research is multidisciplinary, relying on both Proinflammatory cytokine, Cytokine, Toll-like receptor and CD14.
Terje Espevik has researched IκB kinase in several fields, including Tumor necrosis factor alpha and Microbiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
